What is Cladribine?
Category: Prescription Drugs
Most popular types: Mavenclad Leustatin
Cladribine is an antineoplastic agent used in the treatment of hairy cell leukemia. It may also be used in the treatment of chronic lymphocytic leukemia, chronic myelogenous leukemia, non-Hodgkin's lymphomas, progressive multiple sclerosis.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Hairy cell leukemia | 42 | 1 | |
| Multiple sclerosis | 18 | 11 | |
| Improve mobility | 2 | 1 | |
| Langerhans cell histiocytosis | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 2 | |
| Mild | 4 | |
| None | 6 |
Commonly reported side effects and conditions associated with Cladribine
| Side effect | Patients | Percentage |
|---|---|---|
| Acne | 1 | |
| Indigestion | 1 | |
| Insomnia | 1 | |
| Weight gain | 1 |
Why patients stopped taking Cladribine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 10 | |
| Doctor's advice | 3 | |
| Did not seem to work | 1 | |
| Other | 1 |
Duration
Stopped taking Cladribine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 5 | |
| 1 - 6 months | 2 | |
| 6 months - 1 year | 1 | |
| 1 - 2 years | 2 | |
| 2 - 5 years | 3 |
What people switch to and from
Patients started taking Cladribine after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Dimethyl fumarate (Tecfidera) | 2 | |
| Fingolimod (Gilenya) | 1 | |
| Glatiramer acetate (Copaxone) | 1 | |
| Interferon beta-1a SubQ injection (Rebif) | 1 | |
| Interferon beta-1b SubQ Injection (Betaseron) | 1 |
Last updated: